With over 30 years of experience in the life science and molecular diagnostic industry, I am a founder, investor, and advisor who helps innovative biotech companies reach their full potential.I am the CEO of Ansa Biotechnologies, a leading enzymatic DNA synthesis company. I also serve as the founder and managing director of JTG Investments & Advisory UG, my family office, providing strategic and financial guidance and making early investments in emerging life science companies in Europe and the US.In the past, I co-founded and served as CEO of Resolve Biosciences, a company that developed a revolutionary technology for spatial omics and single-cell analysis. I led the company from inception to commercial scaling, securing multiple funding rounds, building a solid team, and successfully launching the first product. Additionally, I held senior executive roles at Inscripta, QIAGEN, Ingenuity Systems, and Affymetrix, where I was instrumental in commercializing disruptive life science tools and solutions, driving them from concept to market ownership. I have a proven track record of increasing sales, growing the bottom line, and spearheading operational improvements and marketing strategies.My passion lies in bringing cutting-edge solutions to life science research and clinical institutions, empowering them to advance scientific discovery and improve outcomes. I excel in articulating the business's vision and value proposition while empowering teams to succeed. I thrive in dynamic, demanding environments while remaining pragmatic and focused. I am consistently seeking new opportunities and challenges to leverage my expertise and network, positively impacting the biotech sector.